Alkermes Inc. plc (ALKS) is a publicly traded Healthcare sector company. As of May 21, 2026, ALKS trades at $37.19 with a market cap of $6.20B and a P/E ratio of 40.06. ALKS moved -0.08% today. Year to date, ALKS is +32.07%; over the trailing twelve months it is +16.77%. Its 52-week range spans $25.17 to $39.56. Analyst consensus is strong buy with an average price target of $45.75. Rallies surfaces ALKS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alkermes Inc. plc (ALKS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ALKS moved -0.08% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $37.19 |
| Market Cap | $6.20B |
| P/E Ratio | 40.06 |
| EPS | $0.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.56 |
| 52-Week Low | $25.17 |
| Volume | 1.52M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.56B |
| Net Income | $152.72M |
| Gross Margin | 86.63% |
15 analysts cover ALKS: 0 strong buy, 12 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.75.